Abstract
We must remove bad representations the medical team has upon the pregnant drug users and the same way in reverse. Opiate substitution treatment (OST) improves prenatal prognosis for both mother and child. There is no need to change OST for a stabilized woman discovering pregnancy. Nevertheless, buprenorphine appears to be first-range medication. OST posology is the most important for prenatal prognosis. Practician must never hesitate to adapt it whether increasing or fractionate it. Neonatal abstinence syndrome (NAS) is not linked with OST's posology. OST is not contra-indicated for breast-feeding. Breast-feeding should be encouraged. It does not treat or cure NAS but allows a skin-to-skin contact that could lessens an occurring withdrawal.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
